Find Academic Supervisors

• Environmental Engineering
• Waste Management
• Wastewater Treatment
• +5 more

Dr. Pascale Champagne is a Professor in the Department of Civil Engineering at Queen’s University with a cross-appointment to the Department of Chemical Engineering. She serves as Director of the Beaty Water Research Centre (on leave) and holds roles such as Scientific Director at the Institut National de la Recherche Scientifique (INRS). Her research focuses on sustainable bioresource management, integrating environmental engineering, chemical engineering, and green chemistry to develop novel waste management strategies and water treatment solutions. Key areas include wastewater treatment, bioenergy production, and the application of microalgae in environmental remediation. Dr. Champagne holds a PhD (2001) and M.A.Sc (1996) in Environmental Engineering from Carleton University, and a B.Sc.Eng (1993) in Water Resources Engineering from the University of Guelph. She has been recognized with prestigious awards, including the NSERC Brockhouse Canada Prize for Interdisciplinary Research (2021) and the Canada Research Chair in Bioresources Engineering (Tier II, 2012). Her research explores innovative technologies for nutrient recovery from wastewater, CO2-responsive polymers for forward osmosis, and the use of cyanobacteria for mine tailings stabilization. Collaborative projects span biofuel development, biorefinery sustainability, and interdisciplinary partnerships with researchers in biology, chemistry, and engineering. Dr. Champagne’s work emphasizes systems approaches to sustainability, addressing challenges in water resource management, circular economy principles, and the mitigation of environmental contaminants such as pharmaceuticals and heavy metals. She actively contributes to policy through roles at Queen’s Institute for Energy and Environmental Policy and has published extensively on topics ranging from algal bioremediation to polymer-modified nanomaterials.

• Muscle Metabolism
• Aging Research
• mTORC1 Signaling
• +6 more

Dr. Stephanie de Alcantara Fernandes is a Minerva Fast Track Group Leader at the Max Planck Institute for Biology of Ageing in Cologne, Germany, where she leads research on muscle metabolism and aging. Her laboratory investigates how spatial and functional regulation of mTORC1 signaling influences skeletal muscle health, growth, and regeneration throughout the lifespan, with implications for understanding and promoting healthy aging. Dr. Fernandes completed her academic training through a distinguished path: PhD in Biology (Summa cum laude, with distinction), University of Cologne/Max Planck Institute for Biology of Ageing (2017-2023) Master of Science in Genetics, University of São Paulo (2015-2017) Bachelor of Science in Biological Sciences, University of São Paulo (2009-2014) Exchange year at University of Birmingham, UK (2013) Her research focuses on skeletal muscle biology, particularly the balance between anabolic and catabolic processes that maintain muscle health. Dr. Fernandes investigates how mTORC1 (mechanistic Target of Rapamycin Complex 1), a central signaling hub, is spatially organized within cells to selectively regulate specific cellular functions in response to different nutrient sources. Her work reveals that mTORC1 is not simply "on or off" but can be finely tuned to control distinct processes in different cellular compartments, particularly in skeletal muscle cells. A key aspect of her research examines how these regulatory mechanisms change with age, contributing to age-related muscle loss (sarcopenia). By understanding the molecular basis of muscle maintenance and regeneration, her laboratory aims to identify targets for interventions that could promote healthier aging and prevent age-related decline in muscle function. Analysis of Dr. Fernandes' publication record shows a clear trajectory of increasingly independent research focused on mTORC1 signaling, nutrient sensing, and their roles in aging and muscle biology. Her most recent work demonstrates sophisticated understanding of mTORC1's spatial regulation, revealing how different pools of mTORC1 respond to distinct amino acid sources to control specific cellular processes. This research bridges fundamental cell biology with translational applications for aging-related conditions. Dr. Fernandes has received numerous prestigious awards recognizing her scientific excellence: Minerva Fast Track Fellowship (2025) - Group Leader Position for Outstanding Female Scientists from Max Planck Society Graduate School for Biological Sciences (GSfBS) doctoral award for 2023 (2025) World Muscle Society Fellowship (2016) Cologne Graduate School of Ageing Research fellowship (2017-2020) Master's scholarship from São Paulo Research Foundation (2015-2017) Science Without Borders Scholarship from Brazilian Council for Scientific and Technological Development (2013) As a newly appointed Group Leader through the Minerva Fast Track program, Dr. Fernandes is establishing her independent research program with substantial institutional support. Her laboratory combines advanced techniques including high-throughput omics approaches (proteomics, metabolomics), molecular biology, biochemistry, cell biology, and super-resolution microscopy. She utilizes multiple model systems including mouse models, skeletal muscle cell lines, and iPSC-derived skeletal muscle cells to identify evolutionarily conserved mechanisms relevant to human health. Dr. Fernandes leads the Minerva Fast Track Group at the Max Planck Institute for Biology of Ageing, which focuses specifically on "Muscle metabolism and aging." Her team investigates how selective mTORC1 signaling is coordinated between different skeletal muscle cell types and how it changes with age, with the ultimate goal of understanding how muscle health can be maintained throughout life.

• Food Science and Technology
• Postharvest Biology
• Food Quality
• +12 more

Dr Natalia Falagan Sama is a Senior Lecturer in Food Science and Technology at Cranfield University, affiliated with the Plant Science Laboratory within the Centre for Soil, Agrifood and Biosciences. Her work focuses on reducing food waste and improving food security through innovative postharvest strategies for fruits and vegetables. University: Cranfield University School: Centre for Soil, Agrifood and Biosciences Department: Plant Science Laboratory Academic Rank: Senior Lecturer Dr Falagan Sama's research centers on understanding the biological mechanisms of ripening and senescence in fresh produce and developing sustainable technologies to extend shelf life. Her expertise spans food quality, food safety, controlled and modified atmosphere storage, and urban agriculture. She investigates how stress responses in crops can be harnessed to maintain nutritional quality and reduce losses across the supply chain. Her work integrates plant physiology, food engineering, and sustainable systems thinking. Her recent publications highlight a strong focus on postharvest biology, sustainable packaging, cold chain optimization, and the role of urban agriculture in food security. Trends in her research show increasing emphasis on climate resilience, net-zero food systems, and the societal impacts of food production, particularly during crises like the COVID-19 pandemic. She frequently publishes in high-impact journals such as Postharvest Biology and Technology , Journal of the Science of Food and Agriculture , and Frontiers in Plant Science . Top 50 Women in Engineering: Engineering Heroes award (2021) Medal from the Royal Academy of Engineering (Spain) (2022) Best Research Supervisor at Cranfield University (2023) Dr Falagan Sama advises on major research projects funded by BBSRC, GCRF, ESRC, and NERC, including initiatives on avocado waste reduction in Mexico and the Rurban Revolution for resilient UK food systems. She collaborates with clients such as the World Bank, Johnson Matthey, and the Department of International Trade. As a STEM ambassador, she leads the Postharvest Technology module for MSc students and is a Fellow of the Higher Education Academy. She contributes to policy through advisory roles in the Food Standards Agency, the Cool Coalition, and the African Centre of Excellence for Sustainable Cooling and Cold Chain. She is actively involved in research teams focusing on sustainable food systems, cold chain innovation, and urban agriculture resilience. Her labs and projects emphasize interdisciplinary collaboration, integrating plant science, engineering, and social science to address global food challenges.

Subramaniam GaneshView profile

Professor

• Neurodegenerative disorders
• Human molecular genetics
• Protein quality control
• +3 more

Subramaniam Ganesh is a Professor at the Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur (IITK). His research focuses on neurodegenerative disorders, particularly Lafora disease, and the molecular genetics of protein misfolding and autophagy. Education: BSc (1988), MSc (1990) from University of Madras, PhD (1996) from Banaras Hindu University Professional Affiliations: IITK (2002–present), RIKEN Brain Science Institute (1998–2002), Indian Institute of Science (1997–1998) Research Interests: Dr. Ganesh's work spans three main areas: (1) molecular pathology of Lafora disease through genetic screening and cellular models, (2) mechanisms of disorders caused by amino acid repeat expansions with focus on polyglutamine toxicity, and (3) genetic determinants of complex disorders like stroke and asthma. His group employs clinical genetics, cell biology, and biochemical approaches to uncover shared mechanisms in neurodegenerative diseases. Publication Trends: Recent articles highlight his work on glycogen metabolism in neurodegeneration, autophagy regulation in Lafora disease, and cross-disciplinary studies linking diabetes to Alzheimer's pathology. Keywords across 15 most recent papers include Neuroscience , Genetics , Biochemistry , and Pharmacology , with sub-fields spanning Protein degradation , Metabolic stress , and Neuroinflammation . Scientific Awards: National Bioscience Award for Career Development (2008) Scopus Young Indian Scientists Award (2008) B.M. Birla Science Prize (2008) DAE-SRC Outstanding Research Investigator Award (2010) CDRI Award (2012) ICMR Basanti Devi Amir Chand Prize (2014) OPPI Scientist Award (2016) Advising & Collaborations: Mentored 30+ PhD/MSc students since 2002. Collaborated with institutions like RIKEN, IISc Bangalore, and CDRI Lucknow. Editorial roles include Chief Editor of IITK Directions and Associate Editor of Journal of Genetics . Laboratory & Team: Head of the Ganesh Laboratory at IITK, overseeing 20+ researchers including postdoctoral fellows, PhD students, and technical staff. Key projects involve molecular pathways in Lafora disease, protein quality control, and neurodegenerative therapeutics.

James W. BartolomeView profile

Professor

• Rangeland Ecology
• Savanna Ecosystems
• Grassland Management
• +3 more

James W. Bartolome is Professor of Rangeland Ecology at UC Berkeley, focusing on Mediterranean-type savanna ecosystems and rangeland conservation. His research examines interactions between woody plants, herbaceous vegetation, and grazing animals across ecological scales. Current projects investigate how environmental factors and management practices influence biomass productivity, vegetation structure, and water quality in grasslands. Research outputs demonstrate novel methodologies for monitoring grassland community responses and highlight how properly managed livestock grazing can enhance native plant recovery without degrading water quality. Comparative studies of Mediterranean ecosystems worldwide provide insights into native species enhancement through modified grazing and burning regimes. Educational contributions include graduate seminars in Range Ecology and Ecosystem Planning.

• Biomedical Engineering
• Nanotechnology
• Tumor Therapy
• +4 more

Liu Hongmei is a Researcher and Master's Supervisor at Southern University of Science and Technology's Department of Biomedical Engineering. Holding a Ph.D. from the Chinese Academy of Sciences, she specializes in micro-nano robotics and tissue engineering for tumor therapy, with over 66 publications and 12 patents. Her work bridges biomedical engineering and nanotechnology for precision cancer treatments. B.S., Biological Sciences, Harbin Normal University (2005) M.S., Botany, Northeast Agricultural University (2008) Ph.D., Biochemical Engineering, Chinese Academy of Sciences (2015) Her research focuses on biomaterials engineering , nanoparticle drug delivery , and microenvironment-responsive hydrogels . Key areas include glioma therapy, traumatic brain injury recovery, and intervertebral disc degeneration treatments. Recent work explores pH/ROS/inflammation-triggered hydrogels and bioengineered bacteria for disease modulation. Article trends show a strong emphasis on nanoparticle design (2014-2025) for glioma, hydrogel development (2017-2025) for tissue repair, and biomimetic material synthesis (2023-2025) inspired by spider silk and meniscus structures. Sub-fields span pyroptosis inhibition, epigenetic reprogramming, and microbiome engineering. Jiangsu Science and Technology Award (2020) Jiangsu Medical Science and Technology Award (2020) Jiangsu Educational Science Research Award (2021) Chinese Medical Doctor Association's Outstanding Young Scientist (2018) Liu has supervised numerous projects including National Natural Science Foundation of China grants, Jiangsu Province Key R&D Program funding, and Shenzhen City General Projects. She holds 12 Chinese invention patents and collaborates with institutions like the UNESCO Centre for Higher Education Innovation.

Ernestina SchipaniView profile

Professor

• Skeletal Development
• Hypoxia Biology
• Bone Metabolism
• +4 more

Dr. Ernestina Schipani is the William Wikoff Smith Professor of Orthopedic Surgery at the University of Pennsylvania's Perelman School of Medicine, where she leads a productive research laboratory focused on skeletal development and disease mechanisms. Her groundbreaking work has established fundamental principles in hypoxia biology and G-protein coupled receptor signaling as they relate to skeletal formation and disease processes. Dr. Schipani's educational journey includes: M.D. and Ph.D. from St. Anna School of Advanced Studies-University of Pisa, Italy Her research has transformed our understanding of skeletal development, beginning with her seminal discovery that gain-of-function mutations of PTHR1 cause Jansen disease. She pioneered the concept that hypoxia-driven pathways control skeletal development, revealing how oxygen gradients serve as regulatory signals in tissue morphogenesis. Her laboratory employs genetically modified mouse models and cutting-edge techniques including single-cell RNA sequencing and metabolomics to investigate how hypoxia, mitochondrial metabolism, and metabolic reprogramming influence skeletal development and disease. Analysis of her recent publications shows a dominant focus on hypoxia-inducible factors (particularly HIF-1 and HIF-2) in bone development, metabolism, and disease. Her work spans molecular mechanisms of skeletal formation, therapeutic approaches for bone disorders, and the intersection of mitochondrial function with skeletal health, demonstrating sustained research excellence with continuous NIH funding since 1997. Dr. Schipani's significant contributions to bone research have been recognized through: ASBMR Paula Stern Achievement Award (2019) Continuous ASBMR membership since 1992 ASCI membership since 2005 She actively mentors the next generation of bone researchers, with her laboratory members regularly presenting at major scientific conferences including the Gordon Bone & Teeth Conference and ASBMR meetings. Her NIH-funded research program includes four major focus areas: HIF-1 in endochondral bone development and somitogenesis, HIF-2 in bone mass regulation, and HIFs in soft tissue tumors and cartilage regeneration. The laboratory recently secured an NIH R01 grant to study mitochondrial respiration and growth plate biology. The Schipani Laboratory at McKay Laboratories-University of Pennsylvania maintains an active research program investigating the fundamental biological processes of skeletal development, with particular emphasis on hypoxia signaling and metabolic regulation. Current projects examine how hypoxia-inducible factors regulate bone formation and disease processes, with significant translational potential for developing new therapies for skeletal disorders including osteoporosis and skeletal dysplasias.

Ralf HerwigView profile

Researcher

• Computational Biology
• Bioinformatics
• Systems Biology
• +5 more

Dr. Ralf Herwig is a computational biologist at the Max Planck Institute for Molecular Genetics in Berlin, Germany. His work focuses on statistical methods for integrative analysis of gene expression, proteomics, and metabolomics data to model biological processes in human diseases like cancer and diabetes. He develops tools such as ConsensusPathDB for molecular interaction networks and IsoTools for long-read RNA-seq analysis. Education: Diploma in mathematics (Free University of Berlin), PhD in mathematics/statistics (FU Berlin) on clustering algorithms and information-theoretic methods. Research Interests include computational network biology, multi-omics data integration, machine learning for cancer survival predictions, and alternative splicing analysis. His group pioneered network propagation frameworks to explain drug toxicity and black-box ML models. Key Publications cover deep learning in drug combinations, long-read sequencing for cancer isoforms, and systems biology approaches to metabolic disorders. Tools developed by Herwig's lab are widely cited (~2,500 citations for ConsensusPathDB). Labs & Collaborations: Leads the Herwig Lab, collaborating on projects involving cancer, diabetes, and cardiotoxicity. The lab maintains critical computational resources for the biomedical community.

John PoteView profile

Senior Lecturer

• Environmental Science
• Aquatic Microbiology
• Environmental Pollution
• +7 more

Dr. John Pote is a Senior Lecturer and Researcher at the F.-A. Forel Department of Environmental and Water Sciences, Faculty of Sciences, University of Geneva. He has been a scientific collaborator at the university since 2004, following prior assistant roles at UNIGE and institutions in the Central African Republic and Democratic Republic of the Congo. His work integrates environmental chemistry, microbiology, and risk assessment in aquatic systems. Research Interests: Identification and prevention of organic and inorganic micropollutants (PCBs, PAHs, antibiotics, heavy metals) in lake water and sediments Risk assessment of genetically modified organisms (GMOs) and transgenic DNA transfer in the environment 16S and 18S rRNA characterization of microbial communities in sediment profiles for climate change studies Pharmaceutical pollution in global river systems The trend in his recent publications centers on global environmental contamination, particularly pharmaceuticals in surface waters. His 2022 study in PNAS assessed pharmaceutical pollution across 104 countries, revealing significant ecological and human health risks in over 25% of sampled sites. This work underscores his leadership in international environmental monitoring and policy-relevant science. Scientific Awards and Recognition: No formal awards explicitly mentioned in the provided text. Advising and Grants: Dr. Pote actively supervises and co-directs doctoral theses and postgraduate diplomas. He has been involved in municipal environmental projects related to waste management, wastewater treatment, and general sanitation planning. His roles combine research leadership with practical environmental consultancy. Laboratories and Teams: He manages the aquatic microbiology laboratory and clean room at the University of Geneva and is responsible for trace metal analyses using ICP-MS. He also serves as the Chemical and Biological Safety Officer, indicating leadership in lab operations and safety protocols.

Yoram CohenView profile

Professor

• Environmental Engineering
• Water Desalination
• Membrane Technology
• +3 more

Yoram Cohen is a Professor in the Department of Chemical and Biomolecular Engineering at the University of California, Los Angeles (UCLA). He leads the Polymer and Separations (PolySep) Research Laboratory, focusing on advanced water treatment technologies. Ph.D. in Environment and Sustainability D.Env. in Environmental Science and Engineering B.S. in Environmental Science His research spans membrane technology , surface nano-structuring , and environmental impact analysis . Key areas include: Reverse osmosis and ultrafiltration membrane design Surface crystallization and fouling mitigation Electroactive polymers for contaminant removal Nanoinformatics for environmental health Mathematical modeling of contaminant transport Recent publications emphasize machine learning integration in desalination systems, high-recovery water treatment , and sustainable membrane technologies . His work addresses challenges in decentralized water systems for disadvantaged communities. Pritzker Emerging Environmental Genius Award The PolySep Lab has pioneered innovations in: Surface-modified membranes with polymer brush layers Real-time scaling detection methods Self-adaptive control systems for water treatment

Fabian-Xosé FernandezView profile

Associate Professor

• Circadian Rhythms
• Sleep Science
• Suicide Risk Assessment
• +3 more

Fabian-Xosé Fernandez serves as Associate Professor in the Department of Psychology within the College of Science at the University of Arizona, where he directs the Circadian Trends Laboratory. His research program bridges neuroscience, clinical psychology, and public health through investigations of circadian biology and sleep-wake patterns. His primary research interests focus on circadian fluctuations in real-world data , psychology of nighttime wakefulness , and suicide risk mechanisms . Key investigations explore how nocturnal wakefulness correlates with suicidal ideation, homicide risk, and metabolic dysregulation. His work employs National Violent Death Reporting System analyses Controlled circadian phase-shifting experiments Population-level sleep surveys Translational rodent models Recent publications reveal strong temporal patterns in behavioral health outcomes, with suicide risk peaking during circadian night across diverse populations. His lab develops chronotherapeutic interventions including spectral filtering devices and lighting protocols to optimize circadian alignment. Current work examines how blue-light modifiers affect phase-shifting responses and how sleep disruption mediates psychiatric outcomes in bipolar disorder. Fernandez teaches graduate and undergraduate courses including PSY 350 (Sleep/Wake, Time Cycles, & Life) and PSY 578 (Sleep & Sleep Disorders), with recent instruction through 2025. His academic service includes editorial review for journals like Clocks & Sleep and Neuropsychopharmacology.

James F CarmodyView profile

Professor

• Mindfulness
• Meditation
• Psychological mechanisms
• +5 more

James F Carmody, PhD is a Professor at UMass Chan Medical School with dual appointments in the Department of Medicine and Department of Population and Quantitative Health Sciences, Division of Preventive and Behavioral Medicine. He is a leading researcher in mindfulness-based interventions and their psychological and neural mechanisms, with over forty-five years of meditation practice across Zen, Tibetan, Theravada and Advaita traditions. Education: Ph.D. from University of Iowa, 1971 Dr. Carmody's research focuses on the psychological and neural mechanisms of mindfulness and mind-body processes, examining how these can modify distress and enhance well-being. His work spans evolutionary psychology, stress reduction, meditation practices, and their clinical applications for conditions including chronic pain, PTSD, asthma, and hot flashes. He has made significant contributions to understanding how mindfulness training affects brain structure and function, particularly in relation to emotional regulation and stress response. Analysis of Dr. Carmody's recent publications reveals a consistent focus on mindfulness-based stress reduction (MBSR) across multiple clinical contexts. His work demonstrates expertise in comparative effectiveness research, examining mindfulness against other therapeutic approaches for chronic pain conditions. There's a strong emphasis on identifying specific mechanisms of action and understanding how mindfulness interventions produce clinical benefits across diverse populations from veterans with PTSD to patients with chronic medical conditions. Research Leadership: Principal Investigator on multiple NIH-funded clinical trials Former Director of Research for the Center for Mindfulness Lead investigator on studies examining mindfulness for chronic pain, PTSD, asthma, hot flashes, and smoking cessation Dr. Carmody teaches mindfulness courses for clinicians, focusing on making the conceptualization and psychological mechanisms of mindfulness straightforward, jargon-free, and practically accessible for patient care. His research has been widely featured in national and international media including the New York Times (reaching #1 on the most emailed list), NPR, ABC, and numerous other outlets.

Edzard SpillnerView profile

Professor

• Allergology
• Immunology
• Antibody Engineering
• +3 more

Edzard Spillner is a Professor at the Department of Biological and Chemical Engineering Medical Biotechnology at Aarhus University. His research focuses on allergology, immunology, and antibody engineering, with applications in diagnostics and therapeutic development. He specializes in nanobody engineering, molecular targeting of allergens, and the structural analysis of antibodies involved in immune responses. Key research interests include the design of antibodies for Hymenoptera venom allergy, the role of modified N-glycans in T H 2 responses, and the development of bispecific antibodies for cancer therapy. His work bridges fundamental molecular biology with clinical applications, aiming to address unmet needs in allergy management and targeted cancer treatments. Selected publications highlight advancements in nanobody-based tools for allergen detection, structural insights into IgE epitopes, and the potential of engineered antibodies against tumor antigens. Current projects include the structural-functional characterization of anaphylactic IgE antibodies targeting the alpha-Gal epitope, with implications for allergy diagnosis and therapy. No scientific awards are explicitly mentioned in the provided text. His academic contributions are primarily reflected in his research output and collaborative projects within the Department of Biological and Chemical Engineering.

Daniel HellerView profile

Professor

• Cancer Nanotechnology
• Biomedical Engineering
• Drug Delivery
• +3 more

Daniel Heller is a Professor at Cornell University's Graduate School of Medical Sciences and Head of the Cancer Nanotechnology Laboratory at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College. His interdisciplinary work develops nanotechnologies to revolutionize cancer research, diagnosis, and treatment through engineering innovation. Education: Bachelor of Arts in History, Rice University (2000) PhD in Chemistry, University of Illinois at Urbana-Champaign (2010) Damon Runyon Cancer Research Foundation Postdoctoral Fellowship, MIT Koch Institute (2012) Dr. Heller pioneers cancer nanotechnology with three core research pillars: precision nanomedicines for targeted drug delivery (including blood-brain barrier-penetrating carriers), AI-powered diagnostic sensors for early cancer detection via implantable/wearable platforms, and nanosensors accelerating drug discovery. His lab integrates machine learning with quantum-defect-modified carbon nanotubes to detect multi-analyte cancer fingerprints in serum, enabling real-time biomarker monitoring for high-risk patients and treatment response assessment. Analysis of his recent publications reveals a strategic shift toward clinical translation , with 2021-2023 work focusing on ovarian cancer detection systems and brain metastasis therapies. His Nature Biomedical Engineering (2022) study demonstrates how AI-enhanced nanosensors achieve unprecedented sensitivity in liquid biopsies, while his Nature Materials (2023) paper establishes a mechanistic foundation for nanocarrier-mediated CNS drug delivery—highlighting convergence of nanotechnology, computational biology, and oncology. Scientific Awards: College of Liberal Arts and Sciences Young Alumni Award, University of Illinois (2024) Life Sciences Invention of the Year, UM Ventures (2023) American Institute for Medical and Biological Engineering (AIMBE) Fellow (2021) Pharmacology Teaching and Mentoring Award, Weill Cornell Graduate School (2020) CRS Nanomedicine Junior Faculty Award and American Cancer Society Research Scholar (2018) Pershing Square Sohn Prize (2017) Kavli Fellow, National Academy of Science (2015) Dr. Heller actively mentors graduate students in Pharmacology and Physiology programs, evidenced by his 2020 Teaching Award. His research is funded by competitive grants including the American Cancer Society Research Scholar award and Pershing Square Sohn Prize, supporting high-risk translational projects like implantable sensor clinical validation and next-generation nanocarrier development for treatment-resistant cancers. The Heller Lab operates as a multidisciplinary engine within MSKCC's Sloan Kettering Institute, combining engineers, chemists, and biologists with clinical collaborators. Current initiatives focus on translating ovarian cancer detection platforms to human trials and developing closed-loop therapeutic systems that auto-adjust dosing based on real-time biomarker feedback—positioning nanotechnology at the forefront of precision oncology.

• Neuromuscular physiology
• Synaptic plasticity
• Skeletal muscle regeneration
• +6 more

Paola Lorenzon is an Associate Professor of Physiology at the University of Trieste 's Department of Life Sciences since 2002. She coordinates the International Master's Degree in Neuroscience , serves as Coordinator of the OPBA program , and holds key roles in multiple PhD cycles including Neuroscience and Cognitive Science (XXVIII to XXXVIII cycles) and Biology (SM50). Her research focuses on neuromuscular plasticity , aging effects, and microgravity adaptation mechanisms. Education : Bachelor's in Biological Sciences and PhD in Biochemistry from University of Trieste Research Experience : University of Milan, San Raffaele Milan, University of Ljubljana, University of Bonn Her research spans three main areas: neuromuscular junction plasticity , electrostimulation protocols for muscle regeneration, and Piezo1 ion channels in mechanotransduction. Current projects funded by the Italian Space Agency (MIAG, NEMUSY) investigate muscle atrophy in spaceflight and aging. Notable collaborations include working with Annalisa Bernareggi (electrophysiology), Marina Sciancalepore (electrostimulation), and Alessandra Bosutti (project coordination). Her lab employs primary satellite cell cultures , electrophysiology , and mechanotransduction studies to explore muscle regeneration mechanisms.